Japanese Foundation for Cancer Research ( Site 0401)

Tokyo 135-8550

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) — Completed